Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-02-13
1991-07-09
Rivers, Diana G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 514283, 530330, 530331, 540478, A61K 31475, C07D51904
Patent
active
050306200
ABSTRACT:
A description is given of conjugates of vinca alkaloid of the indole-dihydroindole type with a protein or a protein fragment, corresponding to the general formula ##STR1## in which R.sub.1 denotes a protein or a protein fragment;
REFERENCES:
patent: 3387001 (1968-06-01), Hargrove
patent: 4388305 (1983-06-01), Trouet et al.
patent: 4522750 (1985-06-01), Ades et al.
patent: 4596676 (1986-06-01), Cullinan
patent: 4639456 (1987-01-01), Trouet et al.
patent: 4659839 (1987-04-01), Nicolotti et al.
patent: 4667030 (1987-05-01), Cullinan
patent: 4675400 (1987-06-01), Cullinan
patent: 4828831 (1989-05-01), Hannart et al.
patent: 4831038 (1989-05-01), Trouet et al.
patent: 4870162 (1989-09-01), Trouet et al.
Teale, et al., "Radioimmunoassay of Vinblastine and Vincristine", Br. J. Clin. Pharmac., vol. 4, pp. 169-172 (1977).
Embleton et al., "Antitumour Reactions of Monoclonal Antibody Against a Human Osteogenic-Sarcoma Cell Line", Br. J. Cancer, vol. 43, pp. 582-587 (1981).
Ritz et al., "A Monoclonal Antibody to Human Acute Lymphoblastic Leukaemia Antigen", Nature, vol. 283, pp. 583-585 (1980).
K. Sikora et al., "Human Monoclonal Antibodies to Lung-Cancer Antigens", Br. J. Cancer, vol. 43, pp. 696-700 (1981).
Ball et al., "Monoclonal Antibodies Reactive with Human Myeloid Leukaemia Cells", Clin. Exp. Immunol., vol. 48, pp. 655-665 (1982).
Masuho, et al., "Interaction of Monoclonal Antibodies with Cell Surface Antigens of Human Ovarian Carcinomas", Cancer Research, vol. 44, pp. 2813-2819 (1984).
Thompson et al., "A Human Breast Tissue-Associated Antigen Detected by a Monoclonal Antibody", J.N.C.I., vol. 70, pp. 409-419 (1983).
Kennett et al., "Hybrid Myelomas Producing Antibodies Against a Human Neuroblastoma Antigen Present on Fetal Brain", Science, vol. 203, pp. 1120-1121 (1979).
Koprowski et al., "Study of Antibodies Against Human Melanoma Produced by Somatic Cell Hybrids", Proc. Natl. Acad. Sci. USA, vol. 75, pp. 3405-3409 (1978).
Thompson et al., "Monoclonal Antibodies to Human Colon and Colorect Carcinoma", Br. J. Cancer, vol. 47, pp. 595-605 (1983).
Ball, et al., "Monoclonal Antibodies Reactive with Small Cell Carcinoma of the Lung", J.N.C.I., vol. 72, pp. 593-598 (1984).
Conrad, et al., "Structure-Activity Relationships of Dimeric Catharanthus Alkaloids. 2, Experimental Antitumor Activities of N-Substituted Deacetylvinblastine Amide (Vindesine) Sulfates", Jour. of Medicinal Chemistry, vol. 22, pp. 391-400 (1979).
Means et al., "Chemical Modification of Proteins", Holden Day Inc., pp. 110-111 (1971).
Selective Cytotoxicity Against Human Tumor Cells by a Vindesine-Monoclonal Antibody Conjugate, by M. J. Embleton et al., Br. J. Cancer (1983), 47, 043-049, pp. 43-49.
Monoclonal Antibodies for Targeted Therapy with Vindesine, by G. F. Rowland et al., B.2 Oncology, vol. 30, pp. 375-379.
Localisation and Toxicity Study of a Vindesine-Anti-CEA Conjugate in Patients with Advanced Cancer, by C. H. J. Ford et al., Br. J. Cancer (1983), 47,035-042, pp. 35-42.
A Vindesine-Anti-CEA Conjugate Cytotoxic for Human Cancer Cells in Vitro, by J. R. Johnson et al., Br. J. Cancer (1981), 44,372, pp. 472-475.
Preparation and Some Properties of Maleimido Acids and Maleoyl Derivatives of Peptides, Keller et al., Helvitica chimica Acta, 58, p. 531 (1975).
Hannart Jean A. A.
Rao Kandukuri S. B.
Trouet Andre B. L.
Omnichem
Rivers Diana G.
LandOfFree
Vinblastine derivatives, and pharmaceutical compositions contain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vinblastine derivatives, and pharmaceutical compositions contain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vinblastine derivatives, and pharmaceutical compositions contain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618284